Mathieu Nendaz

Mathieu Nendaz

Auto-generated profile, based on publicly available information

Mathieu Nendaz

Division of General Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland; Unit of Development and Research in Medical Education (UDREM), Faculty of Medicine, University of Geneva, Geneva, Switzerland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2010 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
ECE. Ceriani
E. Ceriani
CCC. Combescure
C. Combescure
GGGrégoire Le Gal
Grégoire Le Gal
MNM. Nendaz
M. Nendaz
TPT. Perneger
T. Perneger
MRMarc Righini
Marc Righini
Summary. Background: Pretest probability assessment is necessary to identify patients in whom pulmonary embolism (PE) can be safely ruled out by a negative D‐dimer without further investigations. Objective: Review and compare the performance of available clinical prediction rules (CPRs) for PE probability assessment. Patients/methods: We identified studies that evaluated a CPR in patients with suspected PE from Embase, Medline and the Cochrane database. We determined the 95% confidence intervals (CIs) of prevalence of PE in the various clinical probability categories of each CPR. Statistical heterogeneity was tested. Results: We identified 9 CPR and included 29 studies representing 31215 patients. Pooled prevalence of PE for three‐level scores (low, intermediate or high clinical probability) was: low, 6% (95% CI, 4–8), intermediate, 23% (95% CI, 18–28) and high, 49% (95% CI, 43–56) for the Wells score; low, 13% (95% CI, 8–19), intermediate, 35% (95% CI, 31–38) and high, 71% (95% CI, 50–89) for the Geneva score; low, 9% (95% CI, 8–11), intermediate, 26% (95% CI, 24–28) and high, 76% (95% CI, 69–82) for the revised Geneva score. Pooled prevalence for two‐level scores (PE likely or PE unlikely) was 8% (95% CI,6–11) and 34% (95% CI,29–40) for the Wells score, and 6% (95% CI, 3–9) and 23% (95% CI, 11–36) for the Charlotte rule. Conclusion: Available CPR for assessing clinical probability of PE show similar accuracy. Existing scores are, however, not equivalent and the choice among various prediction rules and classification schemes (three‐ versus two‐level) must be guided by local prevalence of PE, type of patients considered (outpatients or inpatients) and type of D‐dimer assay applied.

1 December 2014 in JAMA Internal Medicine
Verified
Journal Article
Closed access
PDF file
NGNicolas Garin
Nicolas Garin
DGDaniel Genné
Daniel Genné
SCSebastian Carballo
Sebastian Carballo
CCChristian Chuard
Christian Chuard
GEGerhardt Eich
Gerhardt Eich
APArnaud Perrier
Arnaud Perrier
Research from JAMA Internal Medicine — β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia — A Randomized Noninferiority Trial

15 July 2015 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
EPEva Pfarrwaller
Eva Pfarrwaller
JSJohanna Sommer
Johanna Sommer
CCChristopher Chung
Christopher Chung
HMHubert Maisonneuve
Hubert Maisonneuve
MNMathieu Nendaz
Mathieu Nendaz
DHDagmar M. Haller
Dagmar M. Haller
Increasing the attractiveness of primary care careers is a key step in addressing the growing shortage of primary care physicians. The purpose of this review was to (1) identify interventions aimed at increasing the proportion of undergraduate medical students choosing a primary care specialty, (2) describe the characteristics of these interventions, (3) assess the quality of the studies, and (4) compare the findings to those of a previous literature review within a global context.

1 March 2019 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
SCStéphane Cullati
Stéphane Cullati
NBNaike Bochatay
Naike Bochatay
FMFabienne Maître
Fabienne Maître
TLThierry Laroche
Thierry Laroche
VMVirginie Muller-Juge
Virginie Muller-Juge
MNMathieu R. Nendaz
Mathieu R. Nendaz
To explore professionals' experiences and perceptions of whether, how, and what types of conflicts affected the quality of patient care. We conducted 82 semistructured interviews with randomly selected health care professionals in a Swiss teaching hospital (October 2014 and March 2016). Participants related stories of team conflicts (intra-/interprofessional, among protagonists at the same or different hierarchical levels) and the perceived consequences for patient care. We analyzed quality of care using the dimensions of care proposed by the Institute of Medicine Committee on Quality of Health Care in America (safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity). Seventy-seven of 130 conflicts had no perceived consequences for patient care. Of the 53 conflicts (41%) with potential perceived consequences, the most common were care not provided in a timely manner to patients (delays, longer hospitalization), care not being patient-centered, and less efficient care. Intraprofessional conflicts were linked with less patient-centered care, whereas interprofessional conflicts were linked with less timely care. Conflicts among protagonists at the same hierarchical level were linked with less timely care and less patient-centered care. In some situations, perceived unsatisfactory quality of care generated team conflicts. Based on participants' assessments, 4 of 10 conflict stories had potential consequences for the quality of patient care. The most common consequences were failure to provide timely, patient-centered, and efficient care. Management of hospitals should consider team conflicts as a potential threat to quality of care and support conflict management programs.

1 July 2014 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
MNMathieu Nendaz
Mathieu Nendaz
DSDavid Spirk
David Spirk
DADrahomir Aujesky
Drahomir Aujesky
DHDaniel Hayoz
Daniel Hayoz
JBJuerg beer
Juerg beer
NKNils Kucher
Nils Kucher
Summary: There is a need to validate risk assessment tools for hospitalised medical patients at risk of venous thromboembolism (VTE). We investigated whether a predefined cut-off of the Geneva Risk Score, as compared to the Padua Prediction Score, accurately distinguishes low-risk from high-risk patients regardless of the use of thromboprophylaxis. In the multicentre, prospective Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE) cohort study, 1,478 hospitalised medical patients were enrolled of whom 637 (43%) did not receive thromboprophylaxis. The primary endpoint was symptomatic VTE or VTE-related death at 90 days. The study is registered at ClinicalTrials.gov, number NCT01277536. According to the Geneva Risk Score, the cumulative rate of the primary endpoint was 3.2% (95% confidence interval [CI] 2.2–4.6%) in 962 high-risk vs 0.6% (95% CI 0.2–1.9%) in 516 low-risk patients (p=0.002); among patients without prophylaxis, this rate was 3.5% vs 0.8% (p=0.029), respectively. In comparison, the Padua Prediction Score yielded a cumulative rate of the primary endpoint of 3.5% (95% CI 2.3–5.3%) in 714 high-risk vs 1.1% (95% CI 0.6–2.3%) in 764 lowrisk patients (p=0.002); among patients without prophylaxis, this rate was 3.2% vs 1.5% (p=0.130), respectively. Negative likelihood ratio was 0.28 (95% CI 0.10–0.83) for the Geneva Risk Score and 0.51 (95% CI 0.28–0.93) for the Padua Prediction Score. In conclusion, among hospitalised medical patients, the Geneva Risk Score predicted VTE and VTE-related mortality and compared favourably with the Padua Prediction Score, particularly for its accuracy to identify low-risk patients who do not require thromboprophylaxis.

1 November 2005 in Pédagogie Médicale
Verified
Journal Article
Open access
PDF file
MNMathieu Nendaz
Mathieu Nendaz
BCBernard Charlin
Bernard Charlin
VLVicki Leblanc
Vicki Leblanc
GBGeorges Bordage
Georges Bordage
Pédagogie médicale, revue internationale francophone d éducation médicale, organe officiel d expression de la Société Internationale Francophone d Éducation Médicale (SIFEM)